Centre For Cellular And Molecular Biology

Rediff.com » News » Centre For Cellular And Molecular Biology

News for Centre For Cellular And Molecular Biology

News
Business

CCMB director: BF.7 won't be as severe in India because...

The severity of BF.7 variant of coronavirus in India may not be as serious as it is currently prevailing in China as Indian have already developed 'herd immunity' a top official of CSIR- Centre for......

Why does China have Covid surge and not India?

Allaying fears about BF.7 variant of coronavirus, a prominent scientist on Friday said it is a sub-variant of Omicron strain and that India need not worry too much about its severity on the......

'No need to panic about COVID-19'

'If the government does its job of vaccinating all the population with the booster dose, and also monitoring the virus, and we do our job of wearing a mask and avoiding crowded places, we will be......

Kerala, AP, Chandigarh report 1st Omicron cases; India's tally rises to 38

Kerala, Andhra Pradesh and Chandigarh reported their first Omicron case on Sunday, while Maharashtra and Karnataka each recorded one more case of the COVID-19 variant, taking the tally in the......

Omicron cases a wake-up call for India: Expert

The COVID-19 vaccines administered in India will be effective in the country's fight against the new variant of the virus Omicron and will provide a shield to vaccinated citizens of the country,......

6 professors awarded Infosys Prize 2019 for science and research

The annual award includes a pure gold medal, a citation and a prize purse worth $ 100,000 or its equivalent in the Indian rupees. IMAGE: Addressing an event organised to announce the winners of......

How the Infosys founders are giving back to the start-up ecosystem

'In certain sectors we want to become catalysts, in others we want to encourage.' S D Shibulal discusses Axilor Ventures with Ayan Pramanik and Raghu Krishnan. IMAGE: Along with other......

How this start-up saves lives

The company has been developing donor-derived stem cell platforms for regenerative medicine and drug discovery applications. Image: Subhadra Dravida, founder, Transcell Biologics. ......

Leaving its troubles behind, Shantha Biotechnics makes a fresh start

The biotech company's revenues had fallen to as low as Rs 50 cr after it lost a WHO contract, but now it hopes to reach Rs 700 cr in two years. It's sheer luck that made you succeed in an otherwise......

GMOs - from war to dialog?

Indian scientists who wrote to the PM last week are not entirely rejecting GMOs but instead asking for caution and further testing to establish their safety, writes Rajni Bakshi. When dignitaries......

Rediff News

Centre For Cellular And Molecular Biology

News for Centre For Cellular And Molecular Biology

CCMB director: BF.7 won't be as severe in India because...

Why does China have Covid surge and not India?

'No need to panic about COVID-19'

Kerala, AP, Chandigarh report 1st Omicron cases; India's tally rises to 38

Omicron cases a wake-up call for India: Expert

6 professors awarded Infosys Prize 2019 for science and research

How the Infosys founders are giving back to the start-up ecosystem

How this start-up saves lives

Leaving its troubles behind, Shantha Biotechnics makes a fresh start

GMOs - from war to dialog?

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS